Articles Tagged With:
-
Intravenous Immunoglobulin for Treatment of Autoimmune Epilepsies
Patients with LGI1 and CASPR2 IgG-associated autoimmune epilepsy were identified and randomized to treatment with intravenous immunoglobulin (IVIG) vs. placebo. The authors hypothesized that IVIG would show superiority over placebo, with a primary endpoint of 50% or greater seizure reduction.
-
Rituximab for the Treatment of MOG and AQP4 Antibody Diseases
Based on an observational prospective study of 16 patients with anti-myelin oligodendrocyte protein (MOG) disease and 29 anti-aquaporin-4 disease, the authors report lesser efficacy of rituximab in anti-MOG patients, characterized by higher occurrence of relapses in the anti-MOG group, even while the biological effect of rituximab on memory B-cell suppression was sustained.
-
Neurofilament Light Correlates With Postoperative Delirium Severity
Measurement of postoperative plasma neurofilament light protein (NfL) in plasma appears to have a dose-dependent correlation with delirium severity, independent of inflammation. This observation provides evidence of neuronal injury from delirium.
-
Expensive Price Tags Keep Patients Away From Certain Neurology Meds
High costs have been connected to poor medication adherence for three common neurologic conditions.
-
Four Risks That Could Lead to Unexpected Readmissions for Elderly Patients
Researchers uncover pre- and post-surgery trouble areas that could result in older patients returning to the hospital one month after a procedure.
-
Status Epilepticus
Status epilepticus is a serious medical condition that is defined as a seizure lasting longer than five minutes or more than one seizure without recovery to baseline between seizures.
-
Infectious Disease Alert Updates
Step-Wise Interventions for Hospital-Onset Clostridioides difficile
-
Cefiderocol (Fetroja)
Cefiderocol is a novel siderophore cephalosporin with a wide spectrum of activity against difficult-to-treat gram-negative organisms for which there currently are limited treatment options.
-
Temperature Trajectories to Find Sepsis Subphenotypes
The authors of this study used development and validation cohorts to retrospectively identify temperature trajectories over the first 72 hours from presentation in the setting of sepsis. Patients presenting with hyperthermia that resolved quickly (within the first 24 hours) had lower mortality compared to those with slow resolution or those presenting with hypothermia.
-
Candida auris Resistant to Azole Antifungals, Amphotericin B, and Echinocandins
Infection with Candida auris resistant to azole antifungals, amphotericin B, and echinocandins was identified in three patients in New York. Resistance to echinocandins was first detected after the patients had received an echinocandin as treatment.